Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts

Journal of Investigative Dermatology

Volumn 122, Issue 6, 2004, Pages 1365-1371

  Kye, Kyung Chae ^a   Chae, Eun Kyung ^a   Piao, Yong Jun ^a   Park, Seonyang ^b   Park, Jang Kyu ^a   Kim, Chang Deok ^a   Lee, Jeung Hoon ^a   Suhr, Ki Beom ^a  

^a Chungnam National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Calcium; Mitogen activated protein kinase; Pertussis toxin sensitive g protein; Plasminogen activator inhibitor 1; Protein kinase c; Sphingosylphosphorylcholine

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; PERTUSSIS TOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SPHINGOSYLPHOSPHORYLCHOLINE; TYRPHOSTIN;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING FORCE MICROSCOPY; SKIN FIBROBLAST; WESTERN BLOTTING;

EID: 2942568035     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22615.x     Document Type: Article

References (40)

1. Ancellin N, Hla T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274:18997-19002, 1999
2. Bitar KN, Yamada H: Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol 269:370-6377, 1995
3. Boguslawski G, Lyons D, Harvey KA, Kovala AT, English D: Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun 272:603-609, 2000
4. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL: Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87:709-719, 1996
5. Chan JC, Duszczyszyn DA, Castellino FJ, Ploplis VA: Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 159:1681-1688, 2001
6. 2+-dependent pathway. Am J Physiol 275:1255-C1263, 1998
7. Ciambrone GJ, McKeown-Longo PJ: Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells. J Cell Biol 111:2183-2195, 1990
8. Desai NN, Carlson RO, Mattie ME, et al: Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J Cell Biol 121:1385-1395, 1993
9. Germer M, Kanse SM, Kirkegaard T, Kjoller L, Felding-Habermann B, Goodman S, Preissner KT: Kinetic analysis of integrin-dependent cell adhesion on vitronectin - the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides. Eur J Biochem 253:669-674, 1998
10. Gonda K, Okamoto H, Takuwa N, et al: The novel sphingosine 1-phosphate receptor AGR16 is coupled via pertussis toxin-sensitive and -insensitive G-proteins to multiple signalling pathways. Biochem J 337:67-75, 1999
11. Goodemote KA, Mattie ME, Berger A, Spiegel S: Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem 270:10272-10277, 1995
12. Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L: Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype. Exp Cell Res 248:634-642, 1999
13. Huber K: Plasminogen activator inhibitor type-1 (part one): Basic mechanisms, regulation, and role for thromboembolic disease. J Thromb Thrombolys 11:183-193, 2001
14. Irigoyen JP, Munoz-Canoves P, Montera L, Koziczak M, Nagamine Y: The plasminogen activator system: Biology and regulation. Cell Mol Life Sci 56:104-132, 1999
15. Jensen PJ, Lavker RM: Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo. Cell Growth Differ 7:1793-1804, 1996
16. Lee MJ, Van Brooklyn JR, Thangada S, et al: Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-1555, 1998
17. Li F, Goncalves J, Faughnan K, et al: Targeted inhibition of wound-induced PAI-1 expression alters migration and differentiation in human epidermal keratinocytes. Exp Cell Res 258:245-253, 2000
18. Liscovitch M, Cantley LC: Lipid second messengers. Cell 77:329-334, 1994
19. Masana MI, Brown RC, Pu H, Gurney ME, Dubocovich ML: Cloning and characterization of a new member of the G-protein coupled receptor EDG. Receptor Channel 3:255-262, 1995
20. Mattie M, Brooker G, Spiegel S: Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem 269:3181-3188, 1994
21. Nordt TK, Sawa H, Fujii S, Sobel BE: Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 91:764-770, 1995
22. 2+ mobilization by Sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. J Biol Chem 270:26332-26340, 1995
23. Olivera A, Spiegel S: Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-560, 1993
24. Pins GD, Collins-Pavao ME, Van De Water L, Yarmush ML, Morgan JR: Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. J Invest Dermatol 114:647-653, 2000
25. Providence KM, Kutz SM, Staiano-Coico L, Higgins PJ: PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair. J Cell Physiol 1:269-280, 2000
26. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2:287-292, 1996
27. Romer J, Lund LR, Eriksen J, et al: Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97:803-811, 1991
28. Seufferlein T, Rozengurt E: Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. J Biol Chem 270:24334-24342, 1995
29. Spiegel S: Sphingosine 1-phosphate: A prototype of a new class of second messengers. J Leukoc Biol 65:341-344, 1999
30. Suhr KB, Tsuboi R, Ogawa H: Sphingosylphosphorylcholine stimulates contraction of fibroblast-embedded collagen gel. Br J Dermatol 143:66-71, 2000
31. Suhr KB, Tsuboi R, Seo EY, Piao YJ, Lee JH, Park JK, Ogawa H: Sphingosylphosphorylcholine stimulates cellular fibronectin expression through upregulation of IL-6 in cultured human dermal fibroblasts. Arch Dermatol Res 294:433-437, 2003
32. Sun L, Xu L, Henry FA, Spiegel S, Nielsen TB: A new wound healing agent-sphingosylphosphorylcholine. J Invest Dermatol 1:232-237, 1996
33. Tuan TL, Wu H, Huang EY, et al: Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 162:1579-1589, 2003
34. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE: Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 106:1007-1011, 1996
35. Wakita H, Matsushita K, Nishimura K, Tokura Y, Furukawa F, Takigawa M: Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes. J Invest Dermatol 110:253-258, 1998
36. Wu J, Spiegel S, Sturgill TW: Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 2:11484-11488, 1995
37. Xu Y: Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1:81-88, 2002
38. Xu Y, Zhu K, Hong G, Wu W, Baudhuin LM, Xiao Y, Damron DS: Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol 2:261-267, 2000
39. Yamaguchi F, Tokuda M, Hatase O, Brenner S: Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9. Biochem Biophys Res Commun 227:608-614, 1996
40. Zhu K, Baudhuin LM, Hong G, et al: Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325-11335, 2001